Global translational medicine initiatives and programs

Translational Biomedicine

Volumn 2, Issue 3, 2011, Pages

  Shahzad, Aamir ^a   McLachlan, Craig S ^b   Gault, Judith ^c   Cohrs, Randall J ^d   Wang, Xiangdong ^e   Köhler, Gottfried ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EDUCATION; COST EFFECTIVENESS ANALYSIS; EDUCATION PROGRAM; FUNDING; INDIA; INFORMATION TECHNOLOGY; JAPAN; NATIONAL HEALTH ORGANIZATION; PROFESSIONAL DEVELOPMENT; PROFESSIONAL KNOWLEDGE; PROGRAM DEVELOPMENT; PUBLIC-PRIVATE PARTNERSHIP; SINGAPORE; TRANSLATIONAL RESEARCH; UNITED KINGDOM; UNITED STATES;

EID: 84859602344     PISSN: None     EISSN: 21720479     Source Type: Journal    
DOI: 10.3823/427     Document Type: Article

References (53)

1. The E.U. total health budget for framework 7 Available from: http://ec.europa.eu/research/fp7/index_en.cfm?pg=health.
2. Lord, G.M. and K. Soderquest, Strategies for Translational Research in the United Kingdom. Science Translational Medicine, 2010. 2(53).
3. Lord, G.M., K. Snape, and R.C. Trembath, Translational medicine and the NIHR Biomedical Research Centre concept. Qjm-an International Journal of Medicine, 2008. 101(11): p. 901-906.
4. Lord, G.M. and R.C. Trembath, A strategy for translation. Lancet, 2007. 369(9575): p. 1771-1773.
5. The UK National Institute of Health Research.
6. Lee, Y. and Y. Tee, Reprising the role of the developmental state in cluster development: The biomedical industry in Singapore. Singapore Journal of Tropical Geography, 2009. 30: p. 86-97.
7. Edelson, E. Edelson, S (2010) SciBX 3(42); doi:10.1038/ scibx.2010.1256. SciBX, 2010. 3, 1-2 DOI: 10.1038/scibx.2010.1256.
8. Halliwell, B., The National University of Singapore and what it does. Biointerphases, 2010. 5(3): p. FA15-FA18.
9. Zhang, F., P. Cooke, and F. Wu, State-sponsored Research and Development: A Case Study of China's Biotechnology. Regional Studies, 2011. 45(5): p. 575-595.
10. Wang, X., E. Wang, and F. Marincola, Translational Medicine is developing in China: a new venue for collaboration. J Transl Med, 2011. 4(9): p. 3.
11. Grose, S., Australian committees set to advise on translational medicine. Nat Med, 2009. 15(11): p. 1238.
12. Wartman, S.A., Commentary: Academic health centers: the compelling need for recalibration. Acad Med, 2010. 85(12): p. 1821-2.
13. Fisk, N., et al., Academic health science centres in Australia: let's get competitive MJA, 2011. 194: p. 59-60.
14. Clarke, R., Education programs at the new Australian School of Advanced Medicine at Macquarie University. Medical journal of Australia, 2007(187): p. 685.
15. Ito, Y., New Japanese Graduate School Programs for Human Resources Development in Clinical Research. Quarterly Review 2008. 26: p. 11-25.
16. Tsubouchi, M., et al., Overview of the clinical application of regenerative medicine products in Japan. Health Policy, 2008. 88(1): p. 62-72.
17. Shineha, R., et al., Familiarity and Prudence of the Japanese Public with Research into Induced Pluripotent Stem Cells, and Their Desire for its Proper Regulation. Stem Cell Reviews and Reports, 2010. 6(1): p. 1-7.
18. Bayry, J., S.V. Kaveri, and P. Follette, Indian science: steps to excellence. Science, 2011. 331(6013): p. 29-30.
19. Ahn, M. and A. York, Resource-based and institution-based approaches to biotechnology industry development in Malaysia. Asia Pacific Journal of Management, 2011. 28(2): p. 257.
20. Ng, S., et al., Influential factors to pursue doctorate degree in Malaysia. Procedia - Social and Behavioural Sciences, 2011. 15: p. 2028-2032.
21. Tejasvi, A., Striving to be a global trial hub, in BioSpectrum Asia2011.
22. Collins, F.S., Reengineering translational science: the time is right. Sci Transl Med, 2011. 3(90): p. 90cm17.
23. Paul, S.M., et al., How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nat Rev Drug Discov, 2010. 9(3): p. 203-14.
24. Munos, B., Lessons from 60 years of pharmaceutical innovation. Nat Rev Drug Discov, 2009. 8(12): p. 959-68.
25. Stevens, A.J., et al., The role of public-sector research in the discovery of drugs and vaccines. N Engl J Med, 2011. 364(6): p. 535-41.
26. Manolio, T.A., Genomewide association studies and assessment of the risk of disease. N Engl J Med, 2010. 363(2): p. 166-76.
27. Zycher, B., J.A. DiMasi, and C.P. Milne, Private sector contributions to pharmaceutical science: thirty-five summary case histories. Am J Ther, 2010. 17(1): p. 101-20.
28. Williams, R.S. and S. Desmond-Hellmann, Making translation work. Science, 2011. 332(6036): p. 1359.
29. Linehan, J.H. and A. Chaney, Academic/Industry challenges for medical device development. Sci Transl Med, 2010. 2(63): p. 63mr6.
30. Portilla, L.M., et al., Advancing translational research collaborations. Sci Transl Med, 2010. 2(63): p. 63cm30.
31. Steele, S.J., Working with the CTSA Consortium: what we bring to the table. Sci Transl Med, 2010. 2(63): p. 63mr5.
32. Evans, G. and F. Austin, Collaborations among academia, government, and industry in the diagnostics space: barriers and some ideas for solutions. Sci Transl Med, 2010. 2(63): p. 63mr3.
33. Milne, C.P. and K.I. Kaitin, Translational medicine: an engine of change for bringing new technology to community health. Sci Transl Med, 2009. 1(5): p. 5cm5.
34. Ross, L.F., 360 Degrees of human subjects protections in community-engaged research. Sci Transl Med, 2010. 2(45): p. 45cm23.
35. Consortium, C.a.T.S.A., C.E.K.F.C. Task, and F.o.t.P.o.C. Engagement. Principals of Community Engagement. 2011 August 1, 2011; 2nd:[Available from: http://www.atsdr.cdc.gov/communityengagement/.
36. Selker, H.P., et al., White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin Transl Sci, 2010. 3(1): p. 29-37.
37. Kroenke, K., et al., Training and career development for comparative effectiveness research workforce development: CTSA Consortium Strategic Goal Committee on comparative effectiveness research workgroup on workforce development. Clin Transl Sci, 2010. 3(5): p. 258-62.
38. Helfand, M., et al., A CTSA agenda to advance methods for comparative effectiveness research. Clin Transl Sci, 2011. 4(3): p. 188-98.
39. Berro, M., et al., Support for investigator-initiated clinical research involving investigational drugs or devices: the Clinical and Translational Science Award experience. Acad Med, 2011. 86(2): p. 217-23.
40. Clinical and Translational Science Awards, 2010, http://www.ncrr.nih.gov/clinical_research_resources/clinical_and_translational_science_awards/.
41. Jackson, R.D., et al., Training the translational scientist. Sci Transl Med, 2010. 2(63): p. 63mr2.
42. DuBois, J.M., et al., Instruction in the responsible conduct of research: an inventory of programs and materials within CTSAs. Clin Transl Sci, 2010. 3(3): p. 109-11.
43. Fiske, W.H., et al., Efficacy of cetuximab in the treatment of Menetrier's disease. Sci Transl Med, 2009. 1(8): p. 8ra18.
44. Rose, L.M. and R. Neale, Development of the first inhaled antibiotic for the treatment of cystic fibrosis. Sci Transl Med, 2010. 2(63): p. 63mr4.
45. Hughes, M.E., J. Peeler, and J.B. Hogenesch, Network dynamics to evaluate performance of an academic institution. Sci Transl Med, 2010. 2(53): p. 53ps49.
46. Borner, K., et al., A multi-level systems perspective for the science of team science. Sci Transl Med, 2010. 2(49): p. 49cm24.
47. Yock, P.G., T.J. Brinton, and S.A. Zenios, Teaching biomedical technology innovation as a discipline. Sci Transl Med, 2011. 3(92): p. 92cm18.
48. Connor, E., D. Lombardi, and J. van den Anker, More than baby steps: perspectives on pediatric translational research. Sci Transl Med, 2009. 1(2): p. 2cm2.
49. Portilla, L.M. and B. Alving, Reaping the benefits of biomedical research: partnerships required. Sci Transl Med, 2010. 2(35): p. 35cm17.
50. Rudick, R.A. and D.M. Cosgrove, A radical proposal: integrate clinical investigation into the U.S. health care system. Sci Transl Med, 2009. 1(4): p. 4cm4.
51. Munos, B.H. and W.W. Chin, A call for sharing: adapting pharmaceutical research to new realities. Sci Transl Med, 2009. 1(9): p. 9cm8.
52. Deftos, L.J., Courts complicate industry-academia ties. Science, 2011. 333(6044): p. 823.
53. Aamir Shahzad, R.J.C., Roland Andersson, Xiangdong Wang & Gottfried Köhler, Recommendations for comprehensive translational medicine education and training. Translational Biomedicine, (2011). Vol. 2 (No. 2:1).